Eliot Tatelman retiring as face of Jordan's Furniture brand
The president and public face of a well-known New England company is stepping aside. Jordan's Furniture announced Thursday that Eliot Tatelman "is retiring from daily operations after decades as the face of the brand."
Jordan's says this is a "natural evolution in its leadership," as Tatelman's sons will be taking over. Josh and Michael Tatelman have been co-CEOs for the past five years.
"Jordan's remains proudly family-run, with Josh and Michael continuing the legacy Eliot has built," the company said in a statement. "This transition ensures continued focus on innovation, customer experience, and community impact."
According to a
profile
in the American Home Furnishings Hall of Fame, Eliot Tatelman and his brother Barry took over the family business in the 1970s when it had just five employees. They became a ubiquitous presence on TV and radio commercials, and the company went beyond just selling furniture by adding IMAX theaters, an
Enchanted Village
and other attractions to its stores.
The brothers sold Jordan's Furniture to Warren Buffett's Berkshire Hathaway conglomerate in 1999, and rewarded store employees with 50 cents for every hour that they had been with the company. They continued to run Jordan's together until Barry stepped away in 2006 to start a Broadway production company.
In one of the company's more famous
promotions,
Jordan's gave away more than $30 million worth of free furniture in 2007 when the
Boston Red Sox
won the World Series. Jordan's also supports numerous local charities in New England, and has helped hundreds of foster children
find adoptive families
.
Jordan's locations can be found in Avon, Natick, and Reading, Massachusetts, as well as New Hampshire, Rhode Island, Connecticut and Maine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Bulls rumors: Will Jerry Reinsdorf sell franchise after White Sox decision?
The post Bulls rumors: Will Jerry Reinsdorf sell franchise after White Sox decision? appeared first on ClutchPoints. Two of the Second City's major sports teams, the Chicago White Sox and Chicago Bulls, are owned by the same man, Jerry Reinsdorf, and long-frustrated fans of both franchises are probably wondering when that will no longer be the case. Advertisement Reinsdorf, the owner of the Bulls when they won six NBA championships in the 1990s with Michael Jordan and the owner of the White Sox when they ended an 88-year drought by winning the World Series in 2005, is not well-liked by those fan bases. In fact, Reinsdorf might be among the most widely disliked owners in all of major North American sports after decades of mediocrity in his teams. But there might be light at the end of the tunnel for the White Sox after Reinsdorf agreed to at least put some kind of timetable out there for a transition of power of his MLB team. 'White Sox owner Jerry Reinsdorf, 89, erased all of the speculation that the White Sox would be up for sale any time soon, but does have a succession plan in place beginning in 2029, or perhaps even 2034 when he will turn 98 years old,' USA Today's Bob Nightengale wrote. 'Reinsdorf, who has been hounded by minority owner Justin Ishbia for years to sell controlling interest of the club, finally agreed to potentially sell it to him beginning in 2029, but not a single day earlier. If Reinsdorf or his family still own[s] the team in 2034, Ishbia has the right to purchase the club without Reinsdorf's approval. In exchange, Ishbia is contributing capital this year and in 2026. The plan was put in place months ago, as The Athletic's Jon Greenberg reported, but was not announced until the final day of the owners' meetings on Thursday.' Advertisement But what about the Bulls? Well, according to Nightengale, the NBA franchise will 'remain in the family where his son, Michael, is president and COO.' The Reinsdorf family may ultimately sell the Bulls at some point, especially with NBA franchise values continuing to increase — the Bulls are valued at $5.8 million, according to CNBC — but there is not a publicly known plan for the team if a post-Reinsdorf era were to happen. Related: Chicago Bulls' perfect outcome for No. 12 pick in 2025 NBA Draft
Fox Sports
2 days ago
- Fox Sports
Snake eyes: D-backs' $425 million investment in starting pitching hasn't gone as planned
Associated Press PHOENIX (AP) — The normally budget-conscious Arizona Diamondbacks have been willing to spend big money over the past several years, taking chances on the notoriously volatile market of free agent starting pitching. So far, it's a bet that has come up snake eyes. Over the past 5 1/2 years, Diamondbacks owner Ken Kendrick has committed roughly $425 million to four pitchers — Corbin Burnes, Jordan Montgomery, Eduardo Rodriguez and Madison Bumgarner. The combined return on that investment: A 30-48 record, 5.25 ERA, minus-0.4 WAR and two Tommy John surgeries. Yikes. The latest bad news came on June 1 when Burnes — who signed a $210 million, six-year deal in January — abruptly left a game against the Nationals with right elbow pain. Now he's set to undergo Tommy John surgery and might not return to the mound until 2027. It's a brutal blow for the D-backs, who have a 31-34 record heading into Monday night's game against the Mariners. The 30-year-old Burnes seemed like the safest bet on the market last winter when the D-backs made the signing. The four-time All-Star and 2021 National League Cy Young Award winner had been remarkably consistent and healthy over the previous four seasons, making at least 28 starts every year. 'I might as well do another job if we're going to be scared of bringing in a guy of this caliber on your team,' Arizona's general manager Mike Hazen said at Burnes' introductory news conference. Added Kendrick: 'We're stretching the budget. It won't be the last time.' And for two months, he was everything Hazen, Kendrick and the D-backs hoped for with a 3-2 record and 2.66 ERA. Now he's out for the foreseeable future. It's the latest in a bad run of luck for Arizona's front office. It's also a brutal reminder of the substantial risk in handing out big money to pitchers in an era when injuries are happening at an alarming rate. The D-backs aren't the only team facing the same problem, even in their own division. The Los Angeles Dodgers currently have 14 pitchers on the injured list — including starters Blake Snell, Tyler Glasnow, Roki Sasaki and Tony Gonsolin. Snell has made just two starts this season because of injuries after signing a $182 millon, five-year deal in the offseason. The difference is the Dodgers seem to have nearly unlimited money to keep adding talent. The D-backs do not. The string of disappointing signings started in December 2019, when the D-backs added Bumgarner with a $85 million, five-year deal. The lefty had declined from his peak in the early-to-mid 2010s, when he led the San Francisco Giants to three World Series titles, but there was reason to believe he would be a solid middle-of-the-rotation option. Instead, he regressed even more in the desert, going 15-32 with a 5.23 ERA over a little more than three seasons. The D-backs released him in 2023 after he had a 10.26 ERA through four starts, eating more than $30 million in the process. The D-backs made a surprise run to the World Series that year and invested in a pair of pitchers — Montgomery and Rodriguez — during the ensuing offseason. Montgomery signed a $25 million, one-year deal with a vesting option for 2025. Rodriguez was added on an $80 million, four-year deal. Much like the Bumgarner signing, both seemed like good deals at the time. Montgomery had just helped the Rangers beat the Diamondbacks in the World Series and was a solid lefty with a sub-4.00 ERA in each of the previous three seasons. Rodriguez was coming off one of the best seasons of his career after going 13-9 with a 3.30 ERA for the Detroit Tigers. Things haven't worked out for either pitcher. Montgomery was awful in 2024 with a 6.23 ERA and eventually demoted to the bullpen. But because he made 21 starts, his vesting option for $22.5 million kicked in for 2025. His bid for a bounce-back season ended before it even started. The lefty got hurt during spring training in March and needed Tommy John surgery for the second time in his career, ending his time in the desert. Rodriguez hurt his shoulder during spring training in 2024 and didn't make his D-backs debut until August, contributing a 5.04 ERA as the team faded down the stretch and missed the playoffs. He's battled injuries and ineffectiveness again this year with a 6.70 ERA through 10 starts. There's still time for the Rodriguez and Burnes deals to take a turn for the better. Even if Burnes doesn't return until 2027, he'd have four more years remaining on his deal. D-backs manager Torey Lovullo chose to remain optimistic following Burnes' injury. 'We're all with Corbin right now,' Lovullo said. 'This is a tough day to get this news. But we'll find a way to rally around him, play hard for him all year long. ... It's a long road, and it takes time for him to heal and recover. And he will. He'll be great for the Arizona Diamondbacks, I'm convinced of it.' ___ AP MLB: recommended
Yahoo
2 days ago
- Yahoo
AMD price target, Intuitive Surgical downgrade: Trending Tickers
Citi analysts lifted their price target for Advanced Micro Devices (AMD) to $120 from $100, highlighting potential positive catalysts in the second half of the year. Deutsche Bank downgraded Intuitive Surgical (ISRG) to Sell from Neutral and cut its price target for the company to $440. To watch more expert insights and analysis on the latest market action, check out more Wealth here. Now time for some of today's trending tickers. We are watching AMD and Intuitive Surgical. Joining me now, we've got the co-host of Market Domination, Josh Lipton. Josh, let's set the scene for folks first with AMD here. AMD's price target raised to $120 a share from $100 at City. This is ahead of the company's advancing AI day. The firm expects the chip maker to launch its latest AI products later this week and highlight some new customers. Overall analysts expect positive catalyst for AMD heading into the second half of the year, highlighting where the chip maker has some advantages over Nvidia potentially here, Josh. So the interesting about this note, Brad, was they found a lot of good stuff potentially coming for Lisa Su's company, right? I mean, you read through this note. First of all, I thought it was interesting they highlight, hey, it's not just Apple. They're not the only ones with a big tech event this week, right? This is going to be the advancing AI day on June 12th. They expect AMD to launch its latest AI product, highlight new customers, maybe some AWS, maybe even potentially open AI. That would be exciting. They argue AMD does have a few advantages over Nvidia. I thought this part of the note was really interesting. They argue AMD's latest AI product will feature more HBM. They're referring there to high bandwidth memory versus Nvidia's B200 series with substantially lower pricing. Then they talk about even some maybe positive surprises coming up, Brad. They tell their clients about the AI business should ramp for instance in the second half of the year. AMD's Xilinx business, they said should recover. All sounds very exciting, but at the end of the day, they do reiterate a neutral on this one. So they did raise their target as you noted to 120, but they stay on the sidelines. How come? Well, one reason is, they tell clients, quote, we would like more details on AI gross margins and revenue guidance. So they want more financial details, more insight, more info before they would get more bullish. Yeah, shares moving higher right now. 4% will be watching to see what the announcements are. Plus we mentioned Intuitive Surgical. Let's get into that one. Getting a downgrade to sell from hold at Deutsche Bank, citing quote, significant risks to the company's instruments and accessories business here. Taking a look at shares down right now by just shy of 7% right now. Yeah, they get slashed to a sell over there at Deutsche Bank. So they're no longer fans. They're on the sidelines. They say we expect a growing number of Intuitive's customers to explore adoption of remanufactured instruments, given the potentially significant profitability gains. They say about 46% of Intuitive's US INA revenues would be at risk of encroachment by these third-party remanufactured devices. When is this going to be potentially a problem, Brad? Deutsche Bank telling their clients our model assumes no material impact in 2026, but steadily increasing headwinds in 2027 and especially 2028. So they do go to a sell. They do slash their target by the way to 440. Now, most on the street are actually still bullish on the name and they like this thing. There are only two sells, but as we know, that does not mean they're wrong. Yeah, they say within this, about 46% of Intuitive's US INA revenues would be at risk of encroachment by third-party manufactured devices. Not what you want to hear. No, not at all. Josh, thanks so much. Got it. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
